Localization of technetium-99m-sestamibi in diffuse myelodysplastic processes

Journal of Nuclear Medicine

Volumn 37, Issue 3, 1996, Pages 471-473

  Reiman, Robert E ^a   Fetters, Julie K ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

myelodysplastic disorders; technetium 99m sestamibi

Indexed keywords

METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M;

AEROBIC METABOLISM; AGED; ARTICLE; BONE MARROW DISEASE; CASE REPORT; ERYTHROPOIESIS; HUMAN; MALE; MEMBRANE POTENTIAL; MITOCHONDRIAL MEMBRANE; MYELODYSPLASIA; POLYCYTHEMIA VERA; PRIORITY JOURNAL; SIDEROBLASTIC ANEMIA;

AGED; ANEMIA, SIDEROBLASTIC; BONE AND BONES; CORONARY DISEASE; HEART; HUMANS; MALE; MYELODYSPLASTIC SYNDROMES; POLYCYTHEMIA VERA; TECHNETIUM TC 99M SESTAMIBI;

EID: 0029863029     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. O'Doherty MJ, Kettle AG, Wells P, et al. Parathyroid imaging with technetium-99m sestamibi: preoperative localization and tissue uptake studies. J Nucl Med 1992;33 313-318.
2. Oktolun C, Bayhan H, Celasun B, et al Unexpected uptake of technetium-99m hexakis-2-methoxy-isobutylisonitrile in giant lymph node hyperplasia of the mediastinum (Castleman's disease) Eur J Nucl Med 1991;18 856-859.
3. 99mTc hexakis 2-methoxyisoburylisonitrile in benign and malignant lesions in the lungs. Clin Nucl Med 1989;14:333-340.
4. O'Tuama LA, Packard AB, Treves ST. SPECT imaging of pediatric brain tumor with hexakis (methoxybutylisonitrile) technetium(I). J Nucl Med 1990;31:2040-2041.
5. 99mTc MIBI in undifferentiated mesencymal tumor and its metastatic lung lesions. Clin Nucl Med 1992,17:144-145.
6. Caner B, Kitapci M, Aras T, et al Increased accumulation of hexakis (2-methoxybutylisonitrile) technetium(I) in osteosarcoma and its metastatic lymph nodes. J Nucl Med 1991;1977-1978
7. 99mTc MIBI in der nachsorge des differentzierten schilddrusenkarzinoms. Nuklearmedizin 1991;30:115-124.
8. O'Driscoll CM, Baker F, Casey MJ, et al. Localization of recurrent medullary thyroid carcinoma with technetium-99m-methoxybutylisonitrile scintigraphy: a case report. J Nucl Med 1991;32:2281-2283
9. Medolago G, Virotta G, Piti A, et al Abnormal uptake of technetium-99m hexakis-2-methoxyisobutyl isonitrile in a primary cardiac lymphoma Eur J Nucl Med 1992;199:222-225
10. Valentine W. Sideroblastic anemias. In: Williams WJ, Beutler E, Erslev AJ, Rundles RW, eds. Hematology, 2nd ed. New York: McGraw-Hill, 1977.
11. Meckenstock G, Fonatsch C, Heyll A, et al. T-cell receptor gamma/delta expressing acute leukemia emerging from sideroblastic anemia: morphological, immunological and cytogenetic features. Leukemia Res 1992;16:379-384.
12. Gatterman N, Aul C, Schneider W Risk of leukemic transformation in two types of acquired idiopathic sideroblastic anemia. Hematologie und Bluttransfusion 1990;33.374-381.
13. Glass JL, Wasserman LR. Primary polycythemia In: Williams WJ, Beutler E, Erslev AJ, Rundles RW, eds. Hematology, 2nd ed. New York. McGraw-Hill; 1977.
14. Piwnica-Worms D, Kronauge JF, Delmon L, et al Effect of metabolic inhibition on technetium-99m-MIBI kinetics in cultured chick myocardial cells. J Nucl Med 1990:31:464-472
15. 99mTc-based lipophilic cation [Abstract] J Gen Physiol 1989;94:41A.
16. Vykoupil KF Thiel J. Stangel W, et al Polycythemia vera I Histopathology, ultrastructure and cytogenetics of the bone marrow in comparison with secondary polycythemia. Virchows Archiv A Path Anat Histol 1980,389:307-324
17. Van Dyke D, Anger HO, Parker H, et al. Markedly increased blood flow in myelofibrosis. J Nucl Med 1971;12.506-512